Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Ruling Is a Relief for Amgen's Anemia Drugs, but the Storm's Not Over Yet
BNET Pharma
Thursday, February 18, 2010 - 10:56am
tags:
FDA, Amgen, anemia, Epogen, Aranesp
Does India Want Drug Innovation or Not?
WSJ Online
Thursday, February 18, 2010 - 9:40am
tags:
India, innovation
Glaxo, XenoPort face additional FDA questions
Yahoo/AP
Thursday, February 18, 2010 - 9:25am
tags:
FDA, GSK, XenoPort, Horizant, restless legs syndrome
Where Are Merck's Cuts Coming From?
Seeking Alpha
Thursday, February 18, 2010 - 9:20am
tags:
Merck, restructuring, layoffs
J&J Reportedly Cutting Bonus Targets
TheStreet.com
Thursday, February 18, 2010 - 9:19am
tags:
JNJ, bonuses
CombinatoRx will have to wait another week on Exalgo
Fierce Biotech
Wednesday, February 17, 2010 - 6:55pm
tags:
Exalgo, CombinatoRx
J&J's prostate cancer drug proves promising in Ph2
Fierce Biotech
Wednesday, February 17, 2010 - 6:54pm
tags:
prostate cancer, JNJ, abiraterone
Medicines Co. 4Q loss widens on charges
Yahoo/AP
Wednesday, February 17, 2010 - 6:51pm
tags:
earnings, Medicines Company
Merck's Marginal Merger: $3.5B in Savings From Layoffs That Cost $3.3B
BNET Pharma
Wednesday, February 17, 2010 - 3:38pm
tags:
Merck, layoffs
$1.24 Billion Deal. Shares Fall 9%. That Makes Sense (Rigel)
Motley Fool
Wednesday, February 17, 2010 - 3:36pm
tags:
Rigel, AstraZeneca, arthritis, partnerships
Top 10 drugs from new Merck, new Pfizer
Fierce Pharma
Wednesday, February 17, 2010 - 11:08am
tags:
Merck, Pfizer
Drug stocks edge higher; Genzyme slips
Marketwatch
Wednesday, February 17, 2010 - 11:08am
tags:
drug stocks, Genzyme
Cadence: Why FDA Approval Is Imminent
Seeking Alpha
Wednesday, February 17, 2010 - 10:27am
tags:
FDA, Cadence Pharmaceuticals
Genzyme's quarterly profit falls
Marketwatch
Wednesday, February 17, 2010 - 10:26am
tags:
Genzyme, earnings
Pfizer's Pyramid of Doom, Or How the Drugmaker Oversold the Market for Cholesterol Drugs by 28 Million Americans
BNET Pharma
Wednesday, February 17, 2010 - 9:19am
tags:
Pfizer, Lipitor, off-label, whistleblowers
Ark. announces $18.5M settlement with Eli Lilly
Google/AP
Wednesday, February 17, 2010 - 9:16am
tags:
Arkansas, settlements, Zyprexa, Eli Lilly
CSL Profit Beats Estimates on Swine Flu Vaccine Sales
Bloomberg
Wednesday, February 17, 2010 - 9:07am
tags:
earnings, CSL, swine flu, vaccines
Bristol-Myers' Damp Squib: Diabetes Drug Onglyza Nets Only $6M in Q4
BNET Pharma
Wednesday, February 17, 2010 - 9:05am
tags:
diabetes, Onglyza, Bristol-Myers Squibb
Why Teva's Dip on Earnings Is an Opportunity
Seeking Alpha
Wednesday, February 17, 2010 - 9:04am
tags:
Teva Pharmaceuticals, earnings
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wednesday, February 17, 2010 - 9:01am
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.